Establishing an Infrastructure for High-Throughput Short-Interfering RNA Screening.

Hongwei Yin1, Chris Sereduk2, Nanyun Tang2

  • 1Cancer and Cell Biology Division (CCB), Translational Genomics Research Institute (TGen), 445 N. Fifth Street, Phoenix, AZ, 85004, USA. hyin@tgen.org.

Summary

High-throughput RNA interference (RNAi) screening rapidly identifies drug targets and biomarkers by perturbing gene expression. This powerful technology offers insights into drug mechanisms and vulnerabilities, requiring specific infrastructure for successful implementation.